MedTrace Logo

Prevention Ambassadors: Intervention to Promote HIV Service Engagement in the Networks of SSP Clients

NCT06848686 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 210

Last updated 2026-01-29

No results posted yet for this study

Summary

HIV testing and service uptake are infrequent among people who use drugs (PWUD) in the United States. In partnership with a community-based syringe service program (SSP), this project will develop the SSP-based "Prevention Ambassadors" (PA) intervention to promote HIV testing and service uptake among PWUD via the secondary distribution (i.e., peer delivery) of HIV self-testing (HIVST) kits with local HIV service information and referrals to HIV service navigation in the social networks of SSP clients (i.e., PWUD). The PA intervention will then be piloted to assess its preliminary effects, acceptability, and feasibility among PWUD in the Ending the HIV Epidemic priority jurisdiction of Riverside County, California.

Conditions

Interventions

BEHAVIORAL

Prevention Ambassadors

Delivery of prevention supplies and information on local services plus training to build the capacity of PWUD to distribute HIV self-testing (HIVST) kits with information and referrals to other PWUD in their social networks to promote HIV testing and HIV service engagement among PWUD.

BEHAVIORAL

SSP Standard of Care

Delivery of prevention supplies and information on local services.

Sponsors & Collaborators

  • University of California, San Diego

    collaborator OTHER

  • University of California, Riverside

    collaborator OTHER

  • Dap Health

    collaborator OTHER

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • San Diego State University

    lead OTHER

Principal Investigators

  • Heather A Pines · San Diego State University

  • Angela R Bazzi · University of California, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-02-03
Primary Completion
2026-07-31
Completion
2027-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06848686 on ClinicalTrials.gov